SEC Form 4 · accession 0001567619-18-003214
Medpace Holdings, Inc. · MEDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
August J. Troendle
Officer — President & CEO · Director · 10% Owner
Period of report
Sep 25, 2018
Accepted (ET)
Sep 27, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001668397
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Sep 25, 2018 | S | 38,640 | $58.36 | D | 8,989,174 | I | By Medpace Investors, LLC |
| Common StockF1,F4,F3 | Sep 26, 2018 | S | 46,886 | $58.38 | D | 8,942,288 | I | By Medpace Investors, LLC |
| Common StockF1,F5,F3 | Sep 27, 2018 | S | 46,778 | $58.96 | D | 8,895,510 | I | By Medpace Investors, LLC |
| Common Stock | holding | — | — | — | 351,851 | D | ||
| Common Stock | holding | — | — | — | 10,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on August 20, 2018.
- F2The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
- F3The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F4The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $59.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
- F5The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $59.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.